Topcon Healthcare is the lead investor in a pre-Series A funding round for MachineMD, which develops oculometric systems to assess brain function and detect multiple sclerosis, Parkinson’s disease, tumors, evidence of strokes and other troubles.
Buying a membership today will give you:
To continue reading this article register now.